UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Compare zero based budgeting with traditional budgeting to understand differences, benefits, and trade-offs. This intro helps you decide which method suits your money goals.
21,794 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
United Wholesale Mortgage's parent raises its 2026 revenue forecast just before a key Two Harbors Investment vote on ...
Trump's remarks on a major U.S. refinery milestone vault the energy complex into the spotlight, with Marathon Petrole...
Goldman Sachs trimmed its U.S. growth view as Iran-related tensions threaten more than higher oil prices. The shift s...
As mortgage rates shift and originations evolve, loandepot (LDI) 2025 earnings will hinge on rate flow, loan mix, and...
Carvana's board approved a 5-for-1 stock split, pending shareholder approval. The move could widen access for retail ...
Hightower’s active bets in Netflix, Target, and Broadcom surface as Nvidia prepares to unveil new AI developments at ...
CrowdStrike is grabbing renewed attention on Wall Street after reporting record ARR growth and its first GAAP profit,...
Lululemon beat on Q4 revenue and EPS, but 2026 guidance signals slower growth and ongoing governance questions. Inves...
Markets tremble as Iran tensions flare and policy choices loom. This report explains how trump seems have himself cou...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Bitcoin hovers near a critical zone as traders weigh whether a floor is forming or a deeper pullback lies ahead. ETF ...